AMRN Stock Summary and Trading Ideas (Amarin PLC - American Depositary Shares Each Representing One Ordinary Share | NASDAQ:AMRN)

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Amarin PLC - American Depositary Shares Each Representing One Ordinary Share trades on the NASDAQ stock market under the symbol AMRN.

As of January 29, 2025, AMRN stock price declined to $0.56 with 789,681 million shares trading.

AMRN has a beta of 1.02, meaning it tends to be more sensitive to market movements. AMRN has a correlation of 0.04 to the broad based SPY ETF.

AMRN has a market cap of $232.41 million. This is considered a Small Cap stock.

Last quarter Amarin PLC - American Depositary Shares Each Representing One Ordinary Share reported $42 million in Revenue and -$.05 earnings per share. This fell short of revenue expectation by $-2 million and met earnings estimates .

In the last 3 years, AMRN traded as high as $3.82 and as low as $.43.

The top ETF exchange traded funds that AMRN belongs to (by Net Assets): SPDW, GWX, BIB, IBBQ.

AMRN has underperformed the market in the last year with a return of -57.2%, while the SPY ETF gained +24.9%. In the last 3 month period, AMRN fell short of the market, returning -10.8%, while SPY returned +4.0%. However, in the most recent 2 weeks AMRN has outperformed the stock market by returning +9.2%, while SPY returned +3.4%.

AMRN support price is $.56 and resistance is $.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMRN shares will trade within this expected range on the day.